When it was launched in 2005, the goal of the U.S. President’s Malaria Initiative (PMI) was to reduce malaria-related mortality by 50 percent across 15 high-burden countries in sub-Saharan Africa through a rapid scale-up of four proven and highly effective malaria prevention and treatment measures:
- insecticide-treated mosquito nets (ITNs);
- indoor residual spraying (IRS);
- accurate diagnosis and prompt treatment with artemisinin-based combination therapies (ACTs); and
- intermittent preventive treatment of pregnant women(IPTp).
With the passage of the Tom Lantos and Henry J. Hyde Global Leadership against HIV/AIDS, Tuberculosis, and Malaria Act in 2008 [PDF, 239KB], PMI developed a U.S. Government Malaria Strategy for 2009–2014 [PDF, 483KB]. Consistent with this strategy and the increase in annual appropriations supporting PMI, four new countries in sub-Saharan Africa and one regional program in the Greater Mekong Subregion of Southeast Asia were added in 2011.
PMI’s Strategy for 2015-2020 takes into account the progress over the past decade and the new challenges that have arisen. Malaria prevention and control remains a major U.S. foreign assistance objective and PMI’s Strategy fully aligns with the U.S. Government’s vision of ending preventable child and maternal deaths and ending extreme poverty. It is also in line with the goals articulated in the Roll Back Malaria Partnership’s Action and Investment to Defeat Malaria 2016-2030 and World Health Organization’s Global Technical Strategy for Malaria 2016-2030. Under the PMI Strategy for 2015-2020, the U.S. Government’s goal is to work with PMI-supported countries and partners to further reduce malaria deaths and substantially decrease malaria morbidity, towards the long-term goal of elimination. PMI currently works in 24 focus countries in sub-Saharan Africa and supports two country programs and one regional program in the Greater Mekong Subregion in Asia.